Cablivi (caplacizumab)

pCPA File Number: 21295
Negotiation Status:
Negotiations were not pursued
Indication(s):
Acquired Thrombotic Thrombocytopenic Purpura (aTTP)
Sponsor/Manufacturer:
Sanofi-Aventis Canada Inc.
CDA-AMC Project Number:
SR0633-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: